Article
A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation.
The Journal of pathology - 1 Sept 2015
Son Mi-Young, Kwak Jae Eun, Seol Binna, Lee Da Yong, Jeon Hyejin, Cho Yee Sook
Abstract excerpt
GM1 gangliosidosis (GM1) is an inherited neurodegenerative disorder caused by mutations in the lysosomal β-galactosidase (β-gal) gene. Insufficient β-gal activity leads to abnormal accumulation of GM1 gangliosides in tissues, particularly in the central nervous system, resulting in progressive neurodegeneration. Here, we report an in vitro human GM1 model, based on induced pluripotent stem cell (iPSC) technology....
Topics
- Animals
- Biomarkers
- Cell Line
- Cell Shape
- Cellular Reprogramming
- Gangliosidosis, GM1
- Genotype
- Humans
- Immunologic Factors
- Induced Pluripotent Stem Cells
- Inflammasomes
